Welcome To
CNS & Neurological Disorders - Drug Targets

About the Journal

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targetspublishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Ranking and Category

136^th of 253 in Pharmacology & Pharmacy

165^th of 256 in Neuroscience

About Publisher

Bentham Science: An Introduction

We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.

Subscription Information:

All Journals are available online. For information on the Journals and how to order, please visit our web site at: www.benthamscience.com/journal/price-order.php and select "Prices and Ordering" or contact our subscription department at: subscriptions@benthamscience.org

Open Access:

Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.